Corporate restructuring underway and MASTERS-2 clinical trial prioritizedConference call begins at 4:30 p.m. Eastern time todayCLEVELAND--(BUSINESS WIRE)--$ATHX #ARDS--Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three and six months ended June 30, 2022 and provided a business update.S...
Related Keywords
Germany , Australia , Taiwan , Japan , United States , United Kingdom , Texas , Ohio , Bankura , Ankara , Turkey , America , Ellen Gurley , Dan Camardo , Kasey Rosado , Willie Mays , Sarah Busch , Maia Hansen , Business Development Strategy , Linkedin , Twitter , Department Of Defense , Nasdaq , Maxim Group , Armed Forces Radiobiology Research Institute , Athx Inc , Facebook , Uniformed Services University Of The Health Sciences , World Stroke Congress , Ankura Consulting Group , Memorial Hermann Foundation , Corporate Communications , Regenerative Medicine Head Of Nonclinical Development , Technology Enterprise Consortium , Athersys Inc , Operational Highlights , Chief Financial Officer , Chief Operating Officer , Growth Conference , America Securities , Healthcare Conference , Executive Vice President , Regenerative Medicine , Neuroscience Programs , Vice President , Nonclinical Development , Uniformed Services University , Health Sciences , Excellent Outcomes , Texas Health Science Center , Medical Technology Enterprise Consortium , Chief Executive Officer , Excellent Outcome , Private Securities Litigation Reform Act , Nasdaq Listing Rule , Annual Report , Tables Follow , Condensed Consolidated Balance Sheet Data , Consolidated Statements , Except Per Share Amounts ,
comparemela.com © 2020. All Rights Reserved.